In accordance with the Food and Drug Administration's change order for drug manufacturing (import) product approval (Drug Management Division-No. 8185, effective date 2009.8.19), the precautions for using Alprin tablets have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.
Alprin Tablet
Attachments are original documents and may be in Korean. English editions are labeled separately.
Alprinjeong.hwpAlprinjeong.hwp · 18 KBDownload ↓